Navigation Links
Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension
Date:2/23/2011

ziness (8.2%), blood uric acid (3.8%), blood urea (2.8%), and fatigue (2.5%). Most elevations of creatinine were transient and were generally associated with large blood pressure reductions.

About Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc.Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology and gastroenterology treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for diabetes, cardiovascular disease, gastroenterology, neurology and other conditions. To learn more about these Takeda companies, visit www.tpna.com.

About Takeda Pharmaceutical Company LimitedLocated in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com. Contacts: Josephine Zammuto

Takeda Global Research & Development

224-554-2795

josephine.zammuto@tpna.com

Elissa J. Johnsen

Takeda Pharmaceuticals North America

224-554-3185

ejohnsen@tpna.comCorporate Communications Dept.

Takeda Pharmaceutical Company Limited

+81-3-3278-2037
'/>"/>

SOURCE Takeda Global Research & Development Center, Inc., U.S.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Takeda Enters Into Global Strategic Partnerships With Covance and Quintiles
2. Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetact® (pioglitazone HCl and glimepiride)
3. Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
4. Arthritis Foundation and Takeda Launch First-Ever National Gout Public Service Announcement (PSA) Campaign, Urging People Living With Gout to Keep Enjoying Lifes Simple Pleasures
5. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
6. Takeda Responds to FDA Advisory Committee Recommendation
7. Takeda Provides Update on Patent Litigation for ACTOS(R) (pioglitazone HCl) and ACTOplus met(R) (pioglitazone HCl and metformin HCl) in the U.S.
8. CellCentric Licenses Novel Epigenetic Discovery Programme to Takeda
9. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
10. Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate)
11. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 PRNewswire – iBio, ... of a vaccine candidate for the newly emerged ... laboratory using the iBioLaunch™ platform. This validation milestone ... initial antigen sequence information to purification of recombinant ... ) The iBioLaunch platform eliminates the ...
(Date:5/22/2013)... , May 22, 2013 WomanCare ... with an extensive training initiative attended ... (Photo: http://photos.prnewswire.com/prnh/20130522/DC18844 ) (Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) ... LARC), is a highly effective subdermal implant composed ... 75 mg levonorgestrel (a synthetic form of the ...
(Date:5/21/2013)... Concord Medical Services Holdings Limited ("Concord Medical" ... leading specialty hospital management solution provider and operator of ... in China and the parent of Chang,an Hospital, today ... quarter ended March 31, 2013 [1] . ... which consists of net revenues generated from the network ...
Breaking Medicine Technology:iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2Concord Medical Reports First Quarter 2013 Financial Results 2Concord Medical Reports First Quarter 2013 Financial Results 3Concord Medical Reports First Quarter 2013 Financial Results 4Concord Medical Reports First Quarter 2013 Financial Results 5Concord Medical Reports First Quarter 2013 Financial Results 6Concord Medical Reports First Quarter 2013 Financial Results 7Concord Medical Reports First Quarter 2013 Financial Results 8Concord Medical Reports First Quarter 2013 Financial Results 9Concord Medical Reports First Quarter 2013 Financial Results 10Concord Medical Reports First Quarter 2013 Financial Results 11Concord Medical Reports First Quarter 2013 Financial Results 12Concord Medical Reports First Quarter 2013 Financial Results 13
(Date:5/22/2013)... The health care crisis in the United States is ... percent of all adults are without health insurance. Further, ... U.S. are related to medical bills. The high price ... patients cannot afford to take their prescriptions as directed by ... That's why MedicationDiscountCard.com is offering savings of up to seventy-five ...
(Date:5/22/2013)... 2013 NBA Draft tickets go on sale to the ... The 2013 NBA Draft will be held at the new Barclays ... Nets. The Barclays Center has already become a mecca for ... Paul McCartney and Beyonce have already booked sold out concerts at ... perform at this state-of-the-art venue. Disney on Ice will also ...
(Date:5/22/2013)... May 22, 2013 Abadir Associates, a ... treatments for optimal results, is offering a new technique ... neck. The practice has successfully treated multiple patients ... “Basically, this approach is for women who want to ... dermatologist Dr. Michelle Abadir of Abadir Associates. ...
(Date:5/22/2013)... - May 22 2013: New research shows that ... in specific regions of the brain that are ... planning actions and in motivation. Dr. Alain ... these decision-making brain regions could underlie addiction. These ... Meeting, the annual meeting of the Canadian Association ...
(Date:5/22/2013)... By Dennis Thompson HealthDay Reporter , , TUESDAY, ... Americans isn,t improving much, with about six in 10 ... in unhealthy behaviors like smoking, heavy drinking or not ... Tuesday by the U.S. Centers for Disease Control and ... of the lifestyle choices that have led to soaring ...
Breaking Medicine News(10 mins):Health News:Lyrica Discount Cards Now Available From MedicationDiscountCard.com 2Health News:2013 NBA Draft Tickets: Cheap Concert Tickets Announces that Official Onsales for the 2013 NBA Draft Begin at 10:00 am Local Time on Wednesday, May 22, 2013 2Health News:Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative 2Health News:Addiction as a disorder of decision-making 2Health News:Americans Still Making Unhealthy Choices: CDC 2Health News:Americans Still Making Unhealthy Choices: CDC 3
... by the U.S. Food and Drug Administration (FDA) for a new ... moderate to severe postmenopausal dyspareunia (painful sexual intercourse) announced Wyeth Pharmaceuticals, ... ... Pa. (Business Wire EON) November 13, 2008 -- "This approval ...
... of nest eggs, homes or jobs, their young children ... Michele C. Thorne, Ph.D., assistant professor of clinical psychology ... director of the Consult Liaison Service at Riley Hospital ... newborn babies pick up on the emotional tones of ...
... Inc.,(Nasdaq: SUPG ), a pharmaceutical company dedicated ... today announced that James S.,Manuso, Ph.D., President and ... Lazard Capital Markets Fifth Annual Healthcare Conference on,Tuesday, ... New York, New York., SuperGen,s presentation at ...
... Dowden Health Media,s,beginnings were reflected in an article written ... the Dowden Dispatch an employee newsletter,which published in the ... Mark Dowden, one of the founders of Dowden Health ... 1988, as he stood,in his parents, kitchen chatting with ...
... repair providers join forces to provide superior customer ... Inc., Multi Vendor,Service announced today that it will ... most respected leaders in the ultrasound transducer repair,industry., ... relationship brings together two of the most reputable,high-quality ...
... assassins, many diseases seem to know exactly what types ... of cells, diseases will inexplicably spare a seemingly identical ... depends largely on the kinds and amounts of proteins ... of molecular biology. For this reason, scientists have struggled ...
Cached Medicine News:Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 2Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 3Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 4Health News:Helping children and teens deal with stress in an uncertain time 2Health News:Dowden Health Media: 20 Years and Growing 2Health News:MEDRAD Multi Vendor Service Forms Alliance with Wetsco 2Health News:MEDRAD Multi Vendor Service Forms Alliance with Wetsco 3Health News:Breakthrough in cell-type analysis offers new ways to study development and disease 2Health News:Breakthrough in cell-type analysis offers new ways to study development and disease 3Health News:Breakthrough in cell-type analysis offers new ways to study development and disease 4
... patients' electronic medical records over ... a Web-enabled software application, physicians ... a patient's cardiology and vascular ... intranet. CardioChart displays patient data-reports, ...
... AllMeds for Cardiology is based on ... customized to serve the specific treatment and ... office., Designed to provide patient care assistance ... coding is accurate, AllMeds for Cardiology's simple ...
... Critical Care & Emergency Medicine. The ... and simple to use device which takes ... the pupillary light reflex (PLR). Now even ... are not discernable to the naked eye ...
... It is estimated that 25% of women and ... the United States, more than half of adults ... and unsightly venous disease., The VenaCure Laser Vein ... for the treatment of varicose veins. VenaCure offers ...
Medicine Products: